Quoin Pharmaceuticals Ltd. (QNRX) fundamentals score
Quoin Pharmaceuticals is a late-stage clinical specialty pharmaceutical company focused on the development and commercialization of therapeutic products that treat rare and orphan diseases for which there are currently either no approved or very limited treatments or cures.
Pharmaceutical Preparations · Healthcare · Listed on NASDAQ
Overall: 4.9 out of 10, Weak long-term fundamentals
- Growth: 3.5/10
- Profitability: not scored
- Financial health: 6.2/10
- Earnings quality: 5.5/10
- Valuation: not scored
Scores are calculated from Quoin Pharmaceuticals Ltd.’s SEC filings, using the 12 months through 2021-12. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom Inc. (DXCM): 8.8/10
- Compugen Ltd. (CGEN): 8.7/10
- Exelixis, Inc. (EXEL): 8.7/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group Inc. (HCSG): 8.5/10